(i)
Immunizing
agents means vaccines and immunoglobulin drugs approved by the federal
Food and Drug Administration to provide immunity against diseases caused by the
infectious agents described in clauses
(a) through
(e) of this subparagraph.
(a) In the case of adults, vaccines against the following
infectious diseases: Hepatitis A, Hepatitis B, Influenza, Pneumococcus,
Diphtheria, Tetanus, Measles, Mumps, Rubella, Varicella, Polio, Pertussis,
Human Papilloma Virus, Meningococcus, Respiratory Syncytial Virus, and Herpes
Zoster;
(b) In the case of infants and children under the age of
18, vaccines against the following infectious diseases: Diphtheria, Tetanus,
Pertussis, Measles, Mumps, Rubella, Varicella, Haemophilus Influenzae Type b
(Hib), Polio, Hepatitis B, Hepatitis A, Influenza, Meningococcus, Pneumococcus,
Rotavirus, Respiratory Syncytial Virus, and Human Papilloma Virus;
(c) immunizing agents against an infectious
disease that causes an epidemic or a community wide outbreak, provided that
such immunizing agents are administered as part of a public health program
established by the Commissioner of the Department of Health, a County
Commissioner of Health, or a County Public Health Director to immunize persons
against the infectious disease during the epidemic or community outbreak of the
infectious disease;
(d) additional
immunizing agents approved by resolution of the Board of Regents upon
recommendation by the commissioner that such additional immunization agents are
safe and effective immunization agents for registered professional nurses to
administer to patients, pursuant to a non-patient specific order and protocol
as prescribed in this section, after consideration of the recommendations of
State and/or nationwide authorities that evaluate the effectiveness and safety
of immunization agents, including but not limited to the Centers for Disease
Control and Prevention of the U.S. Department of Health and Human Services.
Such additional immunization agents, which are not specifically enumerated in
this subparagraph, may be removed by resolution of the Board of Regents, upon
recommendation of the commissioner that such immunization agents are not safe
and effective immunization agents for registered professional nurses to
administer to patients, pursuant to a non-patient specific order and protocol
as prescribed in this section, after consideration of the recommendations of
State and/or nationwide authorities that evaluate the effectiveness and safety
of immunization agents, including but not limited to the Centers for Disease
Control and Prevention of the U.S. Department of Health and Human Services;
and
(e) vaccines that are fully
approved or authorized for emergency use by the federal Food and Drug
Administration to provide immunity against COVID-19 and administered in
accordance with applicable federal Food and Drug Administration requirements
and recommendations.